Creating a new generation of small molecule protease inhibitors

News

KalVista Pharmaceuticals Appoints Edward P. Feener, Ph.D. as Chief Scientific Officer

29 November 2016 Read more...

KalVista Pharmaceuticals Announces Closing of Merger with Carbylan Therapeutics

22 November 2016 Read more...